Eplerenone Tablet, Film Coated
Product Images NDC 16729-293

5 FDA label images from Accord Healthcare, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eplerenone (NDC 16729-293). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Eplerenone Fig 3)

Figure (Eplerenone Fig 3)
A dose-response graph titled 'Eplerenone Dose Response – Trough Cuff SBP Placebo-Subtracted Adjusted Mean Change from Baseline in Hypertension Studies.' The chart plots reduction in systolic blood pressure (SBP) in mm Hg on the vertical axis against daily Eplerenone dose in mg on the horizontal axis, showing data points from three studies with different dosing regimens (QD and BID).*
FDA Label Image

Figure (Eplerenone Fig 4)

Figure (Eplerenone Fig 4)
A line chart titled 'Eplerenone Dose Response – Trough Cuff DBP Placebo-Subtracted Adjusted Mean Change from Baseline in Hypertension Studies' depicting the relationship between Eplerenone dose (mg/day) on the x-axis and reduction in diastolic blood pressure (DBP) in mmHg on the y-axis. The chart includes data points from three studies with different dosing regimens: Study 1 QD, Study 2 QD, and Study 2 BID, showing varying reductions in DBP across doses up to 200 mg/day.*
FDA Label Image

Principal Display Panel (25 mg Tablet)

Principal Display Panel (25 mg Tablet)
Label for Eplerenone tablets, 25 mg film-coated oral tablets. The label indicates a package containing 30 tablets, manufactured for Accord Healthcare, Inc., Durham, NC, and by Intas Pharmaceuticals Limited, India. Storage instructions specify 25°C with allowable excursions, and the label states Rx only with NDC 16729-293-10.*
FDA Label Image

Principal Display Panel (50 mg Tablet)

Principal Display Panel (50 mg Tablet)
Label for Eplerenone 50 mg film-coated tablets from Accord Healthcare, Inc. The label indicates a package containing 30 tablets for oral use. It includes dosage storage instructions and manufacturing information for Accord Healthcare, Inc. and Intas Pharmaceuticals Limited, India.*
FDA Label Image

Chemical Structure (Eplerenone Struc)

Chemical Structure (Eplerenone Struc)
Chemical structure of eplerenone showing its steroidal framework with multiple ring structures and functional groups, including ketone and lactone moieties.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.